Cynerio poised to enter U.S. healthcare cybersecurity market

Cynerio said it has completed a $7 million funding round to fuel growth in North America for its healthcare-focused cybersecurity platform.

Investors include global venture capital firms, Accelmed, an unidentified medtech investment firm, and RDC, and RDC, a joint venture between Israeli investment firm Elron and Israeli defense systems manufacturer Rafael.

“Cynerio is committed to protecting the future of healthcare by focusing on its weakest link – the connected medical devices and Internet of Medical Things (IoMT),” said Cynerio CEO Leon Lerman in a prepared statement. “We are delivering a tailor-made, healthcare-driven solution for providers to ensure patient safety and data protection while maintaining operational continuity.”

Cynerio was founded by cybersecurity experts Lerman and Daniel Brodie, CTO, to deliver a cybersecurity solution designed for healthcare providers. The company said its technology analyzes the medical workflows in the IoMT ecosystem for all entities on the network, provides an ongoing healthcare-specific risk analysis, detects anomalies, and stops threats to prevent service disruption, data theft, and compliance violations.

Advisers include John Halamka, M.D.,  a professor of international healthcare innovation at Harvard University and CIO at Beth Israel Deaconess Medical Center in Boston, and Amichai Shulman, co-founder and former CTO of cybersecurity firm Imperva.

Rambam Hospital (Haifa, Israel) and Tel Aviv Medical Center (Tel Aviv, Israel) use Cynerio’s technology, according to the company, which said it is now focused on U.S. market development.

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW